Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis
Syed Huzaifa Khan, MBBS at Nowshera Medical College, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Clinical Cardiology, adding:
“Glad to share our recent publication.
‘Methodological Considerations in Evaluating CTRP12 as a Biomarker for In-Stent Restenosis’.
The paper highlights important considerations including potential selection/verification bias, lack of multivariable adjustment, and the possibility that early post-PCI CTRP12 levels may reflect acute vascular injury and inflammatory activation rather than processes specifically associated with subsequent restenosis.
The authors also discuss the need for appropriate adjustment of clinical and procedural factors and external validation before CTRP12 can be interpreted as an independent biomarker for in-stent restenosis.”
Title: Methodological Considerations in Evaluating CTRP12 as a Biomarker for In‐Stent Restenosis
Authors: Saleha Khattak, Syed Muhammad Rayyan, Syed Huzaifa Khan
Stay updated with Hemostasis Today.
-
Oct 5, 2026, 12:29Mirvat Alasnag: Creating a Space for Women in Cardiovascular Medicine
-
Oct 5, 2026, 11:59Khaoula Mazouzi: The Potential of Haemoglobin Vesicles as an Oxygen Carrier
-
Oct 5, 2026, 11:56Muhammet Özbilen: What Does New Evidence Tell Us About IV Iron in Pregnancy?
-
Oct 5, 2026, 11:42Fonkou Steve: A Moment to Celebrate the Journey Ahead
-
Oct 5, 2026, 11:33Abeeha Faisal: Beyond the Textbooks – A Day With Children Living With Thalassemia
-
Oct 5, 2026, 11:26Jan Zlamal: Honoured with the Fritz Schiff Young Investigator Award by the DGTI
-
Oct 5, 2026, 11:21Umar Mansuri: Can Micronutrient Powders Help Reduce Childhood Anemia?
-
Oct 5, 2026, 11:03Vitalina Dzutseva: Could mRNA Encoded TCEs Transform B Cell Depletion?
-
Oct 5, 2026, 10:50Ligia Carolina Facin: Investigating a Novel Therapeutic Strategy for ATTR-CM